Allogeneic stem cell transplantation for acute lymphoblastic leukemia in adolescents and young adults.Biol Blood Marrow Transplant.(2019).
Associations of complementation group, ALDH2 genotype, and clonal abnormalities with hematological outcome in Japanese patients with Fanconi anemia.Ann Hematol.(2018).
Comparison of chemotherapeutic agents as a myeloablative conditioning with total body irradiation for pediatric acute lymphoblastic leukemia: A study from the pediatric ALL working group of the Japan Society for Hematopoietic Cell Transplantation.Pediatr Blood Cancer.(2015).
Favorable outcome in non-infant children with MLL-AF4-positive acute lymphoblastic leukemia: a report from the Tokyo Children's Cancer Study Group.Int J Hematol.(2015).
Outcome differences between children and adolescents and young adults with non-Hodgkin lymphoma following stem cell transplantation.Int J Hematol.(2016).
Outcome of pediatric acute lymphoblastic leukemia with very late relapse: a retrospective analysis by the Tokyo Children's Cancer Study Group (TCCSG).Int J Hematol.(2014).
Personalized pharmacokinetic targeting with busulfan in allogeneic hematopoietic stem cell transplantation in infants with acute lymphoblastic leukemia.Int J Hematol.(2019).
Safety of Live Attenuated High-titer Varicella-zoster Virus Vaccine in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.Biol Blood Marrow Transplant.(2015).
Unrelated cord blood and bone marrow transplantation in pediatric leukemia.Pediatr Int56, 647-650.(2014).